Network Pharmacology Identifies the Mechanisms of Action of Tongxie Anchang Decoction in the Treatment of Irritable Bowel Syndrome with Diarrhea Predominant
Aim. This study aims to uncover the pharmacological mechanism of Tongxie Anchang Decoction (TXACD), a new and effective traditional Chinese medicine (TCM) prescription, for treating irritable bowel syndrome with diarrhea predominant (IBS-D) using network pharmacology. Methods. The active compounds a...
Main Authors: | Xiang Tan, Wenjing Pei, Chune Xie, Zhibin Wang, Tangyou Mao, Xingjie Zhao, Fushun Kou, Qiongqiong Lu, Zhongmei Sun, Xiaoxuan Xue, Junxiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/2723705 |
Similar Items
-
Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway
by: Xiang Tan, et al.
Published: (2021-01-01) -
Effect of TongXie-YaoFang on Cl− and HCO3- Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats
by: Xiaofang Lu, et al.
Published: (2016-01-01) -
Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials.
by: Yun-Kai Dai, et al.
Published: (2018-01-01) -
Targeted therapies for diarrhea-predominant irritable bowel syndrome
by: Olden KW
Published: (2012-05-01) -
Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
by: Lacy BE
Published: (2016-02-01)